The company will be participating in one-to-one meetings with investors as part of scheduled investor engagement activities.
The meeting is scheduled for August 21, 2026 and will be conducted in physical mode in Mumbai.
The purpose of the meeting is for general investor interaction and engagement.
The disclosure explicitly states that no unpublished price sensitive information (UPSI) will be discussed during these interactions.
Relevant press releases and investor presentations proposed to be discussed are available on the company's website at www.fermentabiotech.com and stock exchange portals.
The company noted that changes may occur due to exigencies on the part of the company or investors.
Additional Notes Section
The disclosure was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
No financial data, performance figures, or strategic updates were disclosed in this announcement.
The document was digitally signed by Varadvinayak Vijay Khambete, Company Secretary & Head - Legal (Membership No. A33861).
